"10.1371_journal.pone.0005290","plos one","2009-04-24T00:00:00Z","Xue Cai; Zack Nash; Shannon M Conley; Steven J Fliesler; Mark J Cooper; Muna I Naash","Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America; Departments of Ophthalmology and Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America; Copernicus Therapeutics, Inc., Cleveland, Ohio, United States of America","Conceived and designed the experiments: XC MIN. Performed the experiments: XC SMC. Analyzed the data: XC SMC SJF MJC MIN. Contributed reagents/materials/analysis tools: XC ZN SMC SJF MJC. Wrote the paper: XC SMC SJF MJC MIN.","Mark J. Cooper is an employee of Copernicus Therapuetics and owns stock in the company.",NA,NA,NA,"2009","04","Xue Cai","XC",6,TRUE,2,2,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
